Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Randomized, Multinational Study, Double-blinded for the Immunogenicity and Consistency Evaluation of 3 Hib-MenCY-TT Vaccine Lots and Single-blinded and Controlled for the Evaluation of Safety and Immunogenicity of GSK Biologicals' Haemophilus Influenzae Type b and Neisseria Meningitidis Serogroups C and Y-tetanus Toxoid Conjugate Vaccine Combined (Hib-MenCY-TT) Compared to Monovalent Hib Vaccine in Healthy Infants at 2, 4, 6, and 12 to 15 Months of Age.
Brief Summary: This study evaluates the immunogenicity and consistency of 3 Hib-MenCY-TT vaccine lots and the safety and immunogenicity of Hib-MenCY-TT vaccine compared to a control group receiving licensed Hib conjugate vaccine, when each are co-administered with Pediarix® to healthy infants at 2, 4, and 6 months of age. The study will also evaluate the safety and immunogenicity of Hib-MenCY-TT vaccine compared to a control group receiving licensed Hib conjugate vaccine, when each are co-administered with M-M-R® II and Varivax® at 12 to 15 months of age.


Options:
A: Arm Label: Menhibrix A Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix B Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix C Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: ActHIB Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: ActHIB, Biological: PedvaxHIB | Intervention Type: BIOLOGICAL; Name: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: ActHIB; Assigned to Arm(s): ActHIB Group | Intervention Type: BIOLOGICAL; Name: PedvaxHIB; Assigned to Arm(s): ActHIB Group | Intervention Type: BIOLOGICAL; Name: Pediarix; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: Prevnar; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: M-M-R II; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: Varivax; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group
B: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Biological: Priorix-Tetra™ (MMRV vaccine 208136), Biological: Havrix®, Biological: Prevnar® | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Biological: Priorix-Tetra™ (MMRV vaccine 208136), Biological: Havrix®, Biological: Prevnar® | Arm Label: Group C; Type: ACTIVE_COMPARATOR; Interventions: Biological: ProQuad®, Biological: Havrix®, Biological: Prevnar® | Intervention Type: BIOLOGICAL; Name: Priorix-Tetra™ (MMRV vaccine 208136); Assigned to Arm(s): Group A, Group B | Intervention Type: BIOLOGICAL; Name: ProQuad®; Assigned to Arm(s): Group C | Intervention Type: BIOLOGICAL; Name: Havrix®; Assigned to Arm(s): Group A, Group B, Group C | Intervention Type: BIOLOGICAL; Name: Prevnar®; Assigned to Arm(s): Group A, Group B, Group C
C: Arm Label: HAV Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Havrix® | Arm Label: HAV+MMR+V Group; Type: EXPERIMENTAL; Interventions: Biological: Havrix®, Biological: M-M-R®II, Biological: VARIVAX® | Arm Label: MMR+V→HAV Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Havrix®, Biological: M-M-R®II, Biological: VARIVAX® | Intervention Type: BIOLOGICAL; Name: Havrix®; Assigned to Arm(s): HAV Group, HAV+MMR+V Group, MMR+V→HAV Group | Intervention Type: BIOLOGICAL; Name: M-M-R®II; Assigned to Arm(s): HAV+MMR+V Group, MMR+V→HAV Group | Intervention Type: BIOLOGICAL; Name: VARIVAX®; Assigned to Arm(s): HAV+MMR+V Group, MMR+V→HAV Group
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Biological: Comparator: VAQTA™ (Hepatitis A vaccine), Biological: Comparator: ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine), Biological: Comparator: Prevnar™ (Pneumococcal 7-Valent Conjugate vaccine) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Biological: Comparator: VAQTA™ (Hepatitis A vaccine), Biological: Comparator: ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine), Biological: Comparator: Prevnar™ (Pneumococcal 7-Valent Conjugate vaccine) | Intervention Type: BIOLOGICAL; Name: Comparator: VAQTA™ (Hepatitis A vaccine); Assigned to Arm(s): 1, 2 | Intervention Type: BIOLOGICAL; Name: Comparator: ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine); Assigned to Arm(s): 1, 2 | Intervention Type: BIOLOGICAL; Name: Comparator: Prevnar™ (Pneumococcal 7-Valent Conjugate vaccine); Assigned to Arm(s): 1, 2

Answer: A